Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Imagene AI Launches the Oncology Intelligence (OI) Suite Discovery Program at Oracle AI World

  • OI Suite Discovery Program launches with complimentary access for researchers in biopharma companies and academic centers to accelerate biomarker discovery through an intuitive, no-code interface.

  • CanvOI, running on Oracle Cloud Infrastructure (OCI), is now trained on more than 1.5 million biopsy images across 40+ organs and designed to perform in small early-phase cohorts.

LAS VEGAS, NEVADA / ACCESS Newswire / October 14, 2025 / Imagene AI, a pioneer in multimodal foundation models for precision oncology, announced today the launch of the OI Suite Discovery Program at Oracle AI World. The program provides complimentary access to OI Suite for researchers in biopharma and academic centers, enabling biomarker discovery and predictive modeling in a secure, no-code environment where researchers can explore, refine, and validate hypotheses, accelerating both the quality and pace of discovery.Imagene AI OI Suite Platform

Imagene AI OI Suite Platform

"Cancer continues to have a devastating impact on individuals and families, but with advancements in cloud and AI we have an opportunity to help change this narrative," said Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences. "We are proud to be working with companies like Imagene AI to support breakthroughs in oncology that can help improve outcomes for those afflicted with this disease."

Over the past year, CanvOI, a state-of-the-art pan-cancer foundation model designed to facilitate innovative oncology research and development, has been further trained on more than 1.5 million digitized biopsy images from over 40 organs and tissue types. Running on Oracle Cloud Infrastructure (OCI), the model is designed to perform in small, early-phase cohorts where responder numbers are limited, and biological interactions are complex.

Following a year of invitation-only access with select partners and very positive feedback, Imagene AI is launching the OI Suite Discovery Program. The program gives researchers the ability to generate and validate biomarkers, build predictive models, and review explainable outputs, while exploring and visualizing data, refining questions, and uncovering insights in an intuitive no-code environment.

"Collaborating with Oracle has allowed us to bring the power of CanvOI and OI Suite to life at scale," said Dean Bitan, Co-founder and CEO of Imagene AI. "With the OI Suite Discovery Program, we are empowering research teams to test hypotheses freely, explore biomarker questions, and accelerate discoveries. Powered by OCI, we are driving a new era of discovery in precision oncology."

OI Suite is a SaaS enterprise platform that addresses one of oncology's most pressing challenges: discovering biomarkers and identifying the right patients from limited, heterogeneous data. Researchers use the platform to test biomarker hypotheses, improve patient stratification, and inform trial design and cohort enrichment. The full OI Suite extends beyond histopathology to integrate gene expression, mutational profiles, and longitudinal clinical records through Imagene AI's Cross-Modality Intelligence Engine, enriched by its proprietary real-world data lake.

Imagene AI will also demonstrate the OI Suite at ESMO 2025 in Berlin, October 17-21.

Researchers can request access to the OI Suite Discovery Program here.

-------

Oracle Trademarks: Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company - ushering in the new era of cloud computing.

Contact Information

Avital Rabani
VP of Marketing
media@imagene-ai.com

.

SOURCE: Imagene AI



View the original press release on ACCESS Newswire

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.